Piramal Pharma reports Q3 net loss

Piramal Pharma, a company that makes medicines, recently announced that it lost ₹136 crore in the third quarter of 2025.

This is a big change because they had made a small profit of ₹4 crore in the same period last year.

The company said that this happened because their customers had too much stock and weren't ordering as much.

They also mentioned that there were some delays in getting new orders and some problems with regulations.

However, they are seeing some signs of improvement and have plans to grow in the future.

They are also buying a new medicine called Kenalog, which is used to treat conditions like arthritis and inflammation, from another company for $35 million upfront and possibly more based on how well it does.